国际肿瘤学杂志 ›› 2019, Vol. 46 ›› Issue (4): 211-215.doi: 10.3760/cma.j.issn.1673-422X.2019.04.004

• 论著 • 上一篇    下一篇

肺腺癌患者外周血NLR、PLR以及CEA的水平及其临床意义

王敏,方浩徽   

  1. 安徽省胸科医院呼吸科,合肥   230032
  • 收稿日期:2018-12-06 修回日期:2019-01-28 出版日期:2019-04-08 发布日期:2019-05-29
  • 通讯作者: 方浩徽,Email: 289492020@qq.com E-mail:289492020@qq.com
  • 基金资助:

    安徽省自然科学基金(1508085QH182)

Level and clinical significance of NLR, PLR and CEA in peripheral blood of patients with lung adenocarcinoma

Wang Min, Fang Haohui   

  1. Department of Respiration, Anhui Chest Hospital, Hefei 230022, China
  • Received:2018-12-06 Revised:2019-01-28 Online:2019-04-08 Published:2019-05-29
  • Contact: Fang Haohui, Email: 289492020@qq.com E-mail:289492020@qq.com
  • Supported by:

    Natural Science foundation of Anhui Province of China (1508085QH182)

摘要: 目的   探讨中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)及癌胚抗原(CEA)在肺腺癌患者与肺部良性疾病患者外周血的差异,以及三者联合检测对肺腺癌的诊断价值。方法   收集安徽省胸科医院2015年1月至2018年9月收治的91例肺腺癌患者作为肺腺癌组,105例肺部良性疾病患者作为对照组,采用全自动血液分析仪和免疫荧光定量方法测定入组患者外周血NLR、PLR及CEA水平,采用受试者工作特征(ROC)曲线和曲线下面积(AUC)分析上述指标对肺腺癌的辅助诊断价值。结果   91例肺腺癌患者中,NLR和PLR分别为4.94±0.34和306.99±12.56,均显著高于对照组的2.80±0.13(t=5.882,P<0.001)和161.98±5.07(t=10.710,P<0.001)。肺腺癌组的CEA浓度为(32.71±5.41)ng/ml,高于对照组(3.21±0.21)ng/ml,差异有统计学意义(t=5.453,P<0.001)。NLR在Ⅲ~Ⅳ期患者中为5.74±0.49,显著高于Ⅰ~Ⅱ期的3.59±0.26,差异有统计学意义(t=-3.904,P<0.001);PLR在Ⅲ~Ⅳ期患者中为347.59±14.33,高于Ⅰ~Ⅱ期的238.94±18.53(t=-4.639,P<0.001);CEA在Ⅲ~Ⅳ期患者中为(43.18±8.09)ng/ml,显著高于Ⅰ~Ⅱ期的(15.14±3.49)ng/ml(t=-3.181,P=0.002)。ROC曲线分析结果提示NLR以3.05为临界值时对肺腺癌的诊断敏感性、特异性、准确率分别为72.50%、65.70%、71.42%,PLR以202.41为临界值时分别为83.50%、81.00%、83.95%,CEA以5.92 ng/ml为临界值时分别为85.20%、89.50%、86.42%,三者联合时分别为87.90%、95.20%、89.01%,4种检测方法的敏感性、特异性及准确率差异均有统计学意义(χ2=16.161,P<0.001;χ2=5.984,P=0.014;χ2=5.809,P=0.016);两两比较发现,三者联合的敏感性高于NLR单独检测(χ2=6.787,P=0.009),特异性高于NLR、PLR单独检测(χ2=23.408,P<0.001;χ2=5.879,P=0.015),准确率明显高于三者单独检测(χ2=8.865,P=0.003;χ2=6.665,P=0.010;χ2=4.670,P=0.031)。CEA的AUC为0.900(95%CI为0.849~0.938),显著高于NLR的0.752(95%CI为0.686~0.811),与PLR的0.865(95%CI为0.809~0.910)相比差异无统计学意义,三者联合后AUC为0.940(95%CI为0.897~0.969),显著高于NLR(Z=5.565,P<0.001)、PLR(Z=3.252,P=0.007)及CEA(Z=2.109,P=0.035)。结论  NLR、PLR和CEA在肺腺癌中显著升高,且与分期有关,三者联合检测具有更佳的诊断效能,值得在临床进一步推广。

关键词: 肺肿瘤, 腺癌, 癌胚抗原, 中性粒细胞与淋巴细胞比值, 血小板与淋巴细胞比值

Abstract: Objective  To investigate the difference of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and carcinoembryonic antigen (CEA) in peripheral blood of patients between lung adenocarcinoma and benign lung disease and their diagnostic values in lung adenocarcinoma. Methods  A total of 91 patients with lung adenocarcinoma admitted to Anhui Chest Hospital from January 2015 to September 2018 were collected as lung adenocarcinoma group and 105 patients with benign lung diseases as control group. The levels of NLR, PLR and CEA in peripheral blood of patients were measured by automatic blood analyzer and immunofluorescence quantitative method. The receiver operating characteristic (ROC) curve and area under curve (AUC) were used to analyze the diagnostic value of the above indicators for lung adenocarcinoma. Results  The NLR and PLR of 91 patients with lung adenocarcinoma were 4.94±0.34 and 306.99±12.56 respectively, which were significantly higher than those of the control group [2.80±0.13 (t=5.882, P<0.001) and 161.98±5.07 (t=10.710, P<0.001)]. The concentration of CEA in lung adenocarcinoma group was (32.71±5.41) ng/ml, which was higher than that in the control group [(3.21±0.21) ng/ml, t=5.453, P<0.001]. NLR was 5.74±0.49 in patients with stage ⅢⅣ, significantly higher than 3.59±0.26 in patients with stage Ⅰ-Ⅱ (t=-3.904, P<0.001). PLR was 347.59±14.33 in patients with stage Ⅲ-Ⅳ, higher than 238.94±18.53 in patients with stage Ⅰ-Ⅱ (t=-4.639, P<0.001). The concentration of CEA was (43.18±8.09) ng/ml in patients with stage Ⅲ-Ⅳ, significantly higher than (15.14±3.49) ng/ml in patients with stage Ⅰ-Ⅱ (t=-3.181, P=0.002). The ROC curve analysis showed that the sensitivity, specificity and accuracy of NLR in the diagnosis of lung adenocarcinoma were 72.50%, 65.70%, 71.42% when 3.05 was the value of cut-off, those of PLR were 83.50%, 81.00%, 83.95% when 202.41 was the cut-off, those of CEA were 85.20%, 89.50%, 86.42% when cut-off was 5.92 ng/ml, and those of the combined detection were 87.90%, 95.20%, 89.01%. The sensitivity, specificity and accuracy of the four methods were significantly different (χ2=16.161, P<0.001; χ2=5.984, P=0.014; χ2=5.809, P=0.016). The sensitivity of the combination was higher than that of NLR alone (χ2=6.787, P=0.009), the specificity of the combination was higher than that of NLR and PLR alone (χ2=23.408, P<0.001; χ2=5.879, P=0.015), and the accuracy of combined detection was significantly higher than that of single detection (χ2=8.865, P=0.003; χ2=6.665, P=0.010; χ2=4.670, P=0.031). The AUC of CEA was 0.900 (95%CI: 0.849-0.938), which was significantly higher than NLR′s 0.752 (95%CI: 0.686-0.811), and there was no significant difference between CEA′s 0.900 and PLR′s 0.865 (95%CI: 0.809-0.910). The AUC of the combined detection was 0.940 (95%CI: 0.897-0.969), which was significantly higher than that of NLR (Z=5.565, P<0.001), PLR (Z=3.252, P=0.007), and CEA (Z=2.109, P=0.035). Conclusion  The levels of NLR, PLR and CEA in lung adenocarcinoma are significantly increased, and they are related to staging. The combination detection of the three has the better diagnostic efficacy in lung adenocarcinoma, which is worth for further clinical promotion.

Key words: Lung neoplasms, Adenocarcinoma, Carcinoembryonic antigen, Neutrophil to lymphocyte ratio, Platelet to lymphocyte ratio